High performance liquid chromatography-diode array and electrospray-mass spectrometry analysis of vardenafil, sildenafil, tadalafil, testosterone and local anesthetics in cosmetic creams sold on the Internet web sites
- 1 October 2009
- journal article
- Published by Elsevier BV in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 50 (3), 362-369
- https://doi.org/10.1016/j.jpba.2009.05.022
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Vision Disorders and Phosphodiesterase Type 5 InhibitorsDrug Safety, 2009
- Phosphodiesterase Type-5 Inhibitor and Oxidative StressInternational Journal of Immunopathology and Pharmacology, 2008
- The pharmacological treatment of premature ejaculationBJU International, 2008
- Comparison of phosphodiesterase type 5 (PDE5) inhibitorsPublished by Hindawi Limited ,2006
- Phosphodiesterase type 5 inhibitors’ extended duration of response as a variable in the treatment of erectile dysfunctionInternational Journal Of Impotence Research, 2006
- Phosphodiesterase type 5 inhibitors for erectile dysfunctionBJU International, 2005
- Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunctionNature Reviews Endocrinology, 2005
- Development of an HPLC method for the identification and dosage of non-allowed substances in cosmetic products. Part I: local anaesthetics and antihistaminicsAnalytical and Bioanalytical Chemistry, 2004
- Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trialUrology, 2003
- The effect of topically applied vasoactive agents and testosterone versus testosterone in the treatment of erectile dysfunction in aged men with low sexual interestInternational Journal Of Impotence Research, 2001